DVA Stock Recent News
DVA LATEST HEADLINES
In uncertain markets, it pays to follow proven wisdom -- and few investors have a track record as legendary as Warren Buffett. Since taking over Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) in 1965, Buffett has weathered every market storm and consistently outperformed market benchmarks.
We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (DVA -0.91%) suffered a hacker ambush in recent days, a situation that spooked many investors.
DaVita HealthCare (DVA) concluded the recent trading session at $140.03, signifying a -1.04% move from its prior day's close.
DaVita has been hit with a ransomware attack that has affected some of the kidney-care company's operations.
DaVita said on Monday it had become aware of a ransomware incident that has encrypted some elements of its network, prompting the dialysis firm to implement measures to limit the effect of the breach.
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
The latest trading day saw DaVita HealthCare (DVA) settling at $151.91, representing a -0.69% change from its previous close.
In the most recent trading session, DaVita HealthCare (DVA) closed at $151.37, indicating a +0.39% shift from the previous trading day.
DVA's stable core business and global expansion are offset by rising labor costs and declining commercial mix, creating a mixed outlook for investors.
DaVita HealthCare (DVA) reachead $150.78 at the closing of the latest trading day, reflecting a +0.25% change compared to its last close.